PARLIAMENT QUESTION: BIOE3 POLICY

1. At a Glance

2. Why in the News

3. Background & Evolution

4. Core Static Facts

5. Multi-Dimensional Analysis

Economic - Bridges innovation-to-market gap via shared pilot & pre-commercial infrastructure, reducing capex burden on start-ups/SMEs [S3][S4]. - Targets USD 300 bn bioeconomy by 2030, expanding skilled-workforce employment [S1].

Environmental - Promotes circular bioeconomy and regenerative green growth; aligns with Net Zero (2070) and LiFE mission [S1]. - Bioplastics + carbon-capture vertical directly address fossil-feedstock dependence [S1].

Scientific / Technological - Convergence of AI + biology through dedicated Bio-AI Hubs (Mūlānkur) — first govt scheme to formalise this [S5]. - Smart proteins & precision biotherapeutics push India into next-gen biologics [S2].

Administrative / Governance - Joint DBT–BIRAC delivery model; competitive Calls for Proposals open to start-ups, SMEs, academia, industry [S3][S4]. - Risk: 21-hub network execution depends on PPP capital uptake [S3].

Geopolitical / Strategic - Positions India in global biomanufacturing race vs USA Bioeconomy EO (2022) and EU Bio-based Industries JU [S1].

6. Recent Developments (last 12-18 months)

7. Prelims Hooks

8. Mains Relevance

9. Related Topics to Study Next

10. Common Errors / Trap Areas

11. Sources